Unité de Fabrication des Médicaments S.A (BVMT:UMED)

BVMT:UMED Revenue

In the year 2025, Unité de Fabrication des Médicaments S.A had annual revenue of 148.91M TND with 0.84% growth. Unité de Fabrication des Médicaments S.A had revenue of 76.59M in the half year ending December 31, 2025, with 2.46% growth.

• Revenue: 148.91M
• Revenue Growth: +0.84%
• P/S Ratio: 2.13
• Revenue / Employee: 260.33K
• Employees: 572
• Market Cap: 316.80M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	148.91M	1.24M	0.84%
Dec 31, 2024	147.68M	11.67M	8.58%
Dec 31, 2023	136.00M	39.64M	41.14%
Dec 31, 2022	96.36M	11.85M	14.02%
Dec 31, 2021	84.51M	-6.53M	-7.18%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 13, 2026

Data Sources Report a data error